share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NARAYEN SHANTANU

Pfizer | 4: Statement of changes in beneficial ownership of securities

輝瑞 | 4：持股變動聲明
SEC announcement ·  04/01 13:36
Moomoo AI 已提取核心訊息
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on 03/28/2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholdings, were not disclosed in the announcement. As such, the total value of the shares after the action remains unknown. This information is critical for investors who track insider activities as indicators of a company's financial health and future performance.
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on 03/28/2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholdings, were not disclosed in the announcement. As such, the total value of the shares after the action remains unknown. This information is critical for investors who track insider activities as indicators of a company's financial health and future performance.
輝瑞公司 [PFE] 的舉報人尚塔努·納拉延於2024年3月28日參與了一筆交易。公告中未披露交易的具體細節，例如行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。因此，行動後股票的總價值仍然未知。這些信息對於追蹤內幕活動作爲公司財務狀況和未來業績指標的投資者至關重要。
輝瑞公司 [PFE] 的舉報人尚塔努·納拉延於2024年3月28日參與了一筆交易。公告中未披露交易的具體細節，例如行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。因此，行動後股票的總價值仍然未知。這些信息對於追蹤內幕活動作爲公司財務狀況和未來業績指標的投資者至關重要。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息